These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10111726)

  • 41. [Development of surgical antibioprophylaxis kits: evaluation of the impact on prescribing habits].
    Aouizerate P; Guizard M
    Therapie; 2002; 57(3):214-28. PubMed ID: 12422531
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravenous metronidazole: a drug utilization review in a community hospital.
    Nessim D
    Can J Hosp Pharm; 1987 Feb; 40(1):6-11. PubMed ID: 10281259
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A pilot study of process and outcome assessment in antibiotic therapy.
    Ilersich AL; Rovers JP; Einarson TR
    Can J Hosp Pharm; 1991 Oct; 44(5):251-8, 270. PubMed ID: 10115579
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A lab-pharmacy push to cut drug therapy costs.
    Rydzewski MM
    MLO Med Lab Obs; 1984 Oct; 16(10):63-4, 69. PubMed ID: 10268396
    [No Abstract]   [Full Text] [Related]  

  • 45. Vancomycin in Oregon: who's using it and why.
    Cieslak PR; Strausbaugh LJ; Fleming DW; Ling JM
    Infect Control Hosp Epidemiol; 1999 Aug; 20(8):557-60. PubMed ID: 10466557
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Monitoring antibiotic prescriptions can reduce use and cost of drugs.
    Douglas AS
    Mod Healthc; 1984 Oct; 14(13):106-7. PubMed ID: 10268397
    [No Abstract]   [Full Text] [Related]  

  • 47. Fluconazole dosing in renal impairment: a drug usage evaluation.
    Moody SB; Sveska KJ
    Hosp Formul; 1993 May; 28(5):499-502. PubMed ID: 10125807
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Department of pharmacy-initiated program for streamlining empirical antibiotic therapy.
    Pastel DA; Chang S; Nessim S; Shane R; Morgan MA
    Hosp Pharm; 1992 Jul; 27(7):596-603, 614. PubMed ID: 10119188
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of a pharmacist/physician cooperative target drug monitoring program on prophylactic antibiotic prescribing in obstetrics and gynecology.
    Michael KA; Henderson PL; Newman RB; Blackwelder EN; Caldwell RD
    Hosp Pharm; 1992 Mar; 27(3):213-6. PubMed ID: 10116721
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multidisciplinary approach to cost reduction of C-section prophylaxis.
    Todd MW; Benrubi G
    Hosp Formul; 1990 Apr; 25(4):446-8, 450. PubMed ID: 10104235
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost containment through P & T committee drug utilization review.
    Bender FH; DeMatteo CS
    Hosp Formul; 1984 Aug; 19(8):699-700, 705-7. PubMed ID: 10267391
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical interventions reduce antimicrobial costs.
    Rao S; Machuga D
    Am J Hosp Pharm; 1994 Mar; 51(5):703. PubMed ID: 8203395
    [No Abstract]   [Full Text] [Related]  

  • 53. Changing physician prescribing habits through a cost-effective first generation cephalosporin formulary.
    Cramer R; Wright C
    Hosp Pharm; 1989 Jan; 24(1):33-8. PubMed ID: 10312858
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of staff pharmacists to reduce the inappropriate use of parenteral histamine-2 antagonist therapy.
    Caldwell RD; Davis SK
    Hosp Pharm; 1987 Dec; 22(12):1205-9. PubMed ID: 10285375
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of a target drug monitoring program on the usage of clindamycin.
    Gin AS; Lipinski LA; Honcharik N
    Can J Hosp Pharm; 1994 Apr; 47(2):53-8. PubMed ID: 10134127
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical pharmacy. Target drug programs can reduce some costs and avoid others.
    Cost Containment; 1984 Aug; 6(16):3-6. PubMed ID: 10267698
    [No Abstract]   [Full Text] [Related]  

  • 57. Possible savings with appropriate antibiotic prophylaxis.
    Hodgson T; Lannigan R; Mills D
    Can J Hosp Pharm; 1984; 37(3):95-7. PubMed ID: 10268247
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Developing and implementing guidelines to promote appropriate use of fluconazole therapy in an AIDS clinic.
    Anassi EO; Egbunike IG; Akpaffiong MJ; Ike EN; Cate TR
    Hosp Pharm; 1994 Jun; 29(6):576-8, 581-2, 585-6. PubMed ID: 10134178
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibiotic cost savings from formulary restrictions and physician monitoring in a medical-school-affiliated hospital.
    Woodward RS; Medoff G; Smith MD; Gray JL
    Am J Med; 1987 Nov; 83(5):817-23. PubMed ID: 3674089
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cost-effective management of DUE (drug utilization evaluation) policy through a pharmacy clerkship.
    Julius HC
    Hosp Formul; 1993 Sep; 28(9):789-91. PubMed ID: 10128394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.